East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Somapacitan
Sogroya
Not routinely available
SMC (SMC2629)
04/12/2024

Indication

For the replacement of endogenous growth hormone (GH) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric GHD), and in adults with growth hormone deficiency (adult GHD). SMC restriction: for children aged 3 years and above and adolesc...

For the replacement of endogenous growth hormone (GH) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric GHD), and in adults with growth hormone deficiency (adult GHD). SMC restriction: for children aged 3 years and above and adolescents with growth failure due to growth hormone deficiency (paediatric GHD).

Therapeutic Area

Endocrine system

Status Description

Not Routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines

Formulation

Solution for injection in pre-filled pen

Comments

Link to Advice

SMC2629

Advice Published

11/11/2024

SMC Submission Type

Abbreviated

SMC Status

Restricted